Results 121 to 130 of about 70,632 (264)

Incidence, Progression and Determinants of Diabetic Retinopathy in Type 2 Diabetes in Australasia: A Systematic Review and Meta‐Analysis

open access: yesClinical &Experimental Ophthalmology, EarlyView.
ABSTRACT Background Current evidence on incidence and progression rate of diabetic retinopathy reveals disparities across Australasia, and no pooled estimates are available to guide region‐wide planning. This review and meta‐analysis assesses the overall incidence, determinants and progression of diabetic retinopathy in Australasia.
Getasew Alemu Mersha   +6 more
wiley   +1 more source

Glycated hemoglobin in patients with intracranial meningiomas

open access: yesBrain and Spine, 2022
D. Oreskovic   +5 more
doaj   +1 more source

Effect of interdisciplinary obesity care on metabolic markers and body weight in people with type 2 diabetes in a rural setting: A randomised controlled trial

open access: yesClinical Obesity, Volume 15, Issue 2, April 2025.
Summary Management of type 2 diabetes includes medications that can unintentionally increase obesity and insulin resistance. This unblinded, single‐centre, randomised controlled trial focused on rural Australian adults with type 2 diabetes (aged 18–75 and body mass index [BMI] >30 kg/m2), measuring the effectiveness of a tailored interdisciplinary ...
Giuliana O. Murfet   +3 more
wiley   +1 more source

Undetectable Glycated Hemoglobin (HbA1c): An Interesting Case

open access: yesClinical Diabetology, 2023
Kuowei Chung, Nanhau Huang
doaj   +1 more source

Glycated hemoglobin and dynapenia in community- dwelling older people with and without diabetes: A cross-sectional study. [PDF]

open access: yesJ Diabetes Metab Disord
da Silva AL   +5 more
europepmc   +1 more source

Impact of screening programmes for type 1 diabetes in youth: A systematic review and meta‐analysis

open access: yesDiabetic Medicine, EarlyView.
Abstract Aim To evaluate the impact of anti‐islet antibody (IAb) screening on the general population and first‐degree relatives (FDRs)/high‐risk individuals and evidence‐based follow‐up modalities. Methods We performed this review through systematic searches of PubMed, EMBASE, Cochrane Library, Web of Science, ClinicalTrials.gov and International ...
Roberto Franceschi   +24 more
wiley   +1 more source

Characterising the impact of shift work on diet and glucose variability in healthcare employees living with type 2 diabetes: The Shift‐Diabetes study

open access: yesDiabetic Medicine, EarlyView.
Abstract Aims To characterise differences in dietary intake, glucose variability, and activity in free‐living healthcare shift workers with type 2 diabetes (T2D) across varying work conditions. Methods Healthcare shift workers with T2D were monitored over 10 days, covering night shifts, day shifts, and rest days.
Rachel Gibson   +8 more
wiley   +1 more source

Efficacy and safety of once‐weekly insulins in type 2 diabetes: A systematic review and meta‐analysis

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
Abstract Aims Once‐weekly (OW) insulins represent a promising strategy to reduce injection burden and improve adherence in type 2 diabetes management. This meta‐analysis aimed to quantify pooled effect sizes for key biological and clinical outcomes, integrating new findings from the five large trials published in 2025.
Olivier Bourron, Damien Denimal
wiley   +1 more source

Effectiveness of behavioural economics‐based financial incentives and social feedback on glycaemic control and physical activity in adults with newly diagnosed type 2 diabetes: A randomised control trial

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
Abstract Aims To assess the effectiveness of behavioural economics‐based financial incentive and social comparison feedback in adults with newly diagnosed type 2 diabetes. Materials and Methods We conducted a pragmatic randomised control trial with 6‐month intervention and 3‐month post‐intervention follow‐up.
Cheryl W. Y. Lai   +14 more
wiley   +1 more source

Home - About - Disclaimer - Privacy